A solid price of around 7.5c per share for the SPP will set the company up for a very positive growth in its path towards commercialisation. This will benefit all shareholders since the sooner CVAC is commercialised, the sooner the share price will return very attracive gains.
So lets hope the share price moves upwards now to support what I see as a desirable offer price for the SPP which is in the best interests of not only shareholders but also all the ovarian cancer sufferers.
cheers
Birdseye
solid price for spp
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |